Litigation Details for Duchesnay Inc. v. Hetero Labs Limited (D. Del. 2021)

Duchesnay Inc. v. Hetero Labs Limited (D. Del. 2021)

Docket		Date Filed	2021-04-14
Court	District Court, D. Delaware	Date Terminated	2021-11-17
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	QUATRX PHARMACEUTICALS COMPANY
Patents	6,245,819; 8,236,861; 8,642,079
Attorneys	Daniel M. Silver
Firms	Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Details for Duchesnay Inc. v. Hetero Labs Limited (D. Del. 2021)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2021-06-14	11	Counterclaim AND Answer to Complaint	civil action for patent infringement of United States Patent No. 8,642,079 (“the ’079 patent”) arising under…) (“Complaint”) concerning U.S. Patent No. 8,642,079 (“the ’079 patent”). …that one or more claims of U.S. Patent No. 8,642,079 (“the ’079 patent”) is invalid and/or not infringed…resolution of patent disputes by authorizing a patent owner to sue an ANDA applicant for patent infringement…be an action for patent infringement arising under the Food and Drug Laws and Patent Laws of the United	External link to document
2021-11-17	18	Judgment - Consent	that United States Patent Nos. 8,642,079 ("the '079 patent"); 6,245,819 ("the '…x27;819 patent"); and 8,236,861 ("the ' 861 patent") are patentable, valid and enforceable…expiration of the ' 079 patent, the ' 819 patent, and the ' 861 patent, would infringe one …claims of the ' 079 patent, the ' 819 patent and the '861 patent. 3. Except…expiration of the ' 079 patent, the '819 patent, and the ' 861 patent, Hetero and its successors	External link to document